Impact of an ivermectin mass drug administration program against endemic scabies and strongyloidiasis

伊维菌素大规模给药计划对地方性疥疮和类圆线虫病的影响

• 批准号: nhmrc : 605804
• 负责人: Dr Deborah Holt
• 金额: $ 86万
• 依托单位: Menzies School of Health Research
• 依托单位国家: 澳大利亚
• 项目类别: NHMRC Project Grants
• 财政年份: 2010
• 资助国家: 澳大利亚
• 起止时间: 2010-01-01 至 2012-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/impact-an-ivermectin-scabies-strongyloidiasis/77783
• 关键词: Impact; ivermectin; mass; drug; administration

Overseas studies suggest sustainable and long term benefits can be obtained through the use of ivermectin in mass drug administration programs to control parasitic infections. Our study will be a critical first step in establishing if such a program can be successful in a remote Indigenous community setting, where the disease burden from scabies and strongyloidiasis (threadworm infections) is very high.

海外研究表明，通过在大规模药物管理项目中使用伊维菌素来控制寄生虫感染，可以获得可持续和长期的好处。我们的研究将是关键的第一步，以确定这样的计划是否能在偏远的土著社区取得成功，在那里，溃疡和弓形虫病(线虫感染)造成的疾病负担非常高。